Back to search

University of Patras

Ο ρόλος των Τ-βοηθητικών κυττάρων και των κυτταροκινών τους στην παθογένεια πορεία και πρόγνωση της πολλαπλής σκλήρυνσης

Abstract

dc:description

Multiple sclerosis (MS) is a chronic, inflammatory, demyelinating disease of the central nervous system (CNS) in the pathogenesis of which the immune system plays a crucial role. Although it is still considered to be an autoimmune disorder, the responsible autoantigen(s) remains elusive and the indications for autoimmunity are indirect. Therefore, it is more appropriate to consider it an immune-mediated disease. A central role in the immunological reaction in MS is attributed to helper T- cells (CD4+, mainly Th1 and Th17), which initiate and maintain the immune cascade of events that result in the destruction of myelin in the CNS. A possible mechanism for this could be an imbalance between CNS-specific CD4+ autoreactive T-cells and peripheral suppressive mechanisms, mediated mainly by regulatory T-cells (Tregs). Cytokines are secreted molecules that mediate the functions of cells that produce them, mainly cells of the immune system. The aim of this thesis was to investigate the role of helper T- cells and their cytokines in the pathogenesis, course and prognosis of MS. Because of the complexity of the disease pathogenesis and the number of immune cells involved, we decided to divide our research into three separate studies. The first study (Study A) focused on the regulatory T- cells (CD4+, nTregs) in an attempt to assess their frequencies under different disease states and therapies and their functionality. The second study (Study B) investigated the cytokine profile, both pro- and anti-inflammatory, of newly diagnosed MS patients compared to that of patients with other inflammatory and non- inflammatory neurological diseases and symptomatic controls, in order to test whether there is a particular immunological profile in MS patients, distinguishing them from other patients. The third study (Study C) was a prospective, longterm observational study of MS patients, whose cytokine profile had been assessed at disease diagnosis. The aim of the study was to investigate whether cytokines can be used as biological markers of disease progression and treatment response to IFNβ.In RRMS nTregs are downregulated but functional during the acute phase, and are restored to normal levels in patients in remission or treated with interferon.The results of our study indicate that MS patients have levels of pro- and anti-inflammatory cytokines comparable to SC and patients with NIND. However, they have a Th2 deviation compared to all other subgroups, especially to IND patients, which show the highest Th1 and Th17 deviation. This finding correlates with the increased IgG index in MS patients. Baseline serum IL-17A levels distinguish GR from PR patients, serum IFN-γ levels distinguish PR from noRx patients, and noRx patients (with minimal disability and a benign course) also exhibit minimal inflammation. The cytokine profiles of GR patients vs PR/noRx patients, discriminate the latter groups as those who should obviate treatment with IFNβ.

Degree

thesis:*
Grantor dc:publisher
University of Patras
Year dc:date
2015

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Dimisianos, Nikolaos
  • Δημησιάνος, Νικόλαος

Subjects

dc:subject × 10

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/36023

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Dimisianos, Nikolaos; Δημησιάνος, Νικόλαος. Ο ρόλος των Τ-βοηθητικών κυττάρων και των κυτταροκινών τους στην παθογένεια πορεία και πρόγνωση της πολλαπλής σκλήρυνσης. University of Patras, 2015. http://hdl.handle.net/10442/hedi/36023